Defitelio and Fluconazole drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Defitelio (defibrotide sodium) and Fluconazole (fluconazole). Common drug interactions include cerebral haemorrhage among females and acute graft versus host disease among males.
The phase IV clinical study analyzes what interactions people have when they take Defitelio and Fluconazole. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.
What is Defitelio?
Defitelio has active ingredients of defibrotide sodium. eHealthMe is studying from 4,343 Defitelio users. Check the latest studies of Defitelio.
What is Fluconazole?
Fluconazole has active ingredients of fluconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 70,481 Fluconazole users. Check the latest studies of Fluconazole.
49 people who take Defitelio and Fluconazole together, and have interactions are studied.

What are the common drug interactions of Defitelio and Fluconazole, by gender? *:
female:
- Cerebral haemorrhage (bleeding within the brain)
- Drug resistance (reduction in effectiveness of a drug)
- Febrile neutropenia (fever with reduced white blood cells)
- Hypersensitivity
- Myalgia (muscle pain)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Thrombocytopenia (decrease of platelets in blood)
- Venoocclusive liver disease (small veins in the liver are obstructed)
- Drug ineffective
male:
- Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
- Gingival bleeding (bleeding gums)
- Cardiac arrest
- Diarrhoea
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Lactic acidosis (low ph in body tissues)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Vomiting
- Haematochezia (passage of stools containing blood)
- Abdominal pain
What are the common drug interactions of Defitelio and Fluconazole, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Cardiac arrest
- Diarrhoea
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Vomiting
10-19:
- Cerebral haemorrhage (bleeding within the brain)
- Drug resistance (reduction in effectiveness of a drug)
- Febrile neutropenia (fever with reduced white blood cells)
- Hypersensitivity
- Myalgia (muscle pain)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Thrombocytopenia (decrease of platelets in blood)
- Venoocclusive liver disease (small veins in the liver are obstructed)
- Drug ineffective
- Haemorrhage (bleeding)
20-29:
- Acute lymphocytic leukaemia (cancer of the white blood cells)
- Epistaxis (bleed from the nose)
- Lactic acidosis (low ph in body tissues)
30-39:
n/a
40-49:
n/a
50-59:
- Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
- Gingival bleeding (bleeding gums)
- Haematochezia (passage of stools containing blood)
- Abdominal pain
- Blood bilirubin increased
- Platelet count decreased
- Blood pressure increased
60+:
n/a
What are the existing conditions these people have? *
- Venoocclusive Disease (small veins in the liver are obstructed): 31 people, 63.27%
- Immunodeficiency Disorders: 8 people, 16.33%
- Bone Marrow Conditioning Regimen: 8 people, 16.33%
- Venoocclusive Liver Disease (small veins in the liver are obstructed): 7 people, 14.29%
- Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 7 people, 14.29%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 12.24%
- Sedation: 4 people, 8.16%
- High Blood Pressure: 4 people, 8.16%
- Alloimmunisation (alloimmunity is an immune response to foreign antigens (alloantigens) from members of the same species): 4 people, 8.16%
- Urination - Excessive Volume: 3 people, 6.12%
* Approximation only. Some reports may have incomplete information.
Do you take Defitelio and Fluconazole?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Defitelio (4,343 reports)
- Fluconazole (70,481 reports)
Browse all drug interactions of Defitelio and Fluconazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Defitelio:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Fluconazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Defitelio and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fluconazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on defibrotide sodium and fluconazole (the active ingredients of Defitelio and Fluconazole, respectively), and Defitelio and Fluconazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Miacalcin cause Rosacea? - 5 seconds ago
- Drug interactions of Roxicet and Hydrocortisone - 9 seconds ago
- Drug interactions of Clarithromycin and Roxicet - 10 seconds ago
- Drug interactions of Omeprazole and Lokelma - 14 seconds ago
- Could Clorazepate Dipotassium cause Epilepsy Aggravated? - 17 seconds ago
- Could Sertraline cause Rapid Eye Movements Sleep Abnormal? - 24 seconds ago
- Could Methyldopa cause Hypertensive Crisis? - 49 seconds ago
- Drug interactions of Skelaxin and Provera - 59 seconds ago
- Drug interactions of Potassium Citrate and Ambrisentan - a minute ago
- Drug interactions of Aciphex and Mevacor - a minute ago